| Unique ID issued by UMIN | UMIN000051324 |
|---|---|
| Receipt number | R000058547 |
| Scientific Title | A study for the effect of intake of lactic acid bacteria on abdominal fat |
| Date of disclosure of the study information | 2024/12/01 |
| Last modified on | 2025/08/19 16:42:50 |
A study for the effect of intake of lactic acid bacteria on abdominal fat
A study for the effect of intake of lactic acid bacteria on abdominal fat
A study for the effect of intake of lactic acid bacteria on abdominal fat
A study for the effect of intake of lactic acid bacteria on abdominal fat
| Japan |
Healthy adult
| Adult |
Others
NO
To evaluate the effect of 12-weeks continuous intake of food including lactic acid bacteria on abdominal fat
Efficacy
Abdominal fat
waist circumference, hip circumference, waist circumference / hip circumference, body weight, BMI, body fat percentage, blood index
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Intake of test food daily for 12 weeks
Intake of placebo daily for 12 weeks
| 20 | years-old | <= |
| 64 | years-old | >= |
Male and Female
1. Healthy males and females from 20 to 64 years of age
2. Subjects whose BMI is 23kg/m2 or more and less than 30kg/m2
3. The average blood pressure, triglycerides, HDL-cholesterol, and blood glucose of the people starting intake should be within the reference range for each item
1. Subjects who regularly ingest food, health food or medicine rich in lactic acid bacteria or natto bacteria
2. Subjects who regularly ingest health food or medicine that affects body fat and lipid metabolism
3. Subjects who are judged to be unsuitable for research from the results of the screening test
4. Subjects who may develop allergies related to the study
5. Subjects who exercise excessively
6. Subjects who are on a diet at the time of the screening test
7. Subjects who have a disease requiring regular administration, or who have a history of severe disease
8. Subjects whose physical measurement values, blood pressure values, and clinical inspection values are significantly outside the reference range before starting intake
9. Subjects who have or have a history of a severe disease
10. Subjects who drink a lot
11. Subjects who are judged to be unsuitable for the study based on the results of lifestyle questionnaires
12. Subjects who donated blood within one month before the study
13. Subjects who have participated in other clinical study within one month before the study or plan to participate in other clinical study after informed consent to the study
14. Subjects who are pregnant or breastfeeding, or plan to do so during this study
15. Subjects judged as unsuitable for the study by a doctor
80
| 1st name | Yuki |
| Middle name | |
| Last name | Higuchi |
KAMEDA SEIKA Co., Ltd.
Rice Research Institute
950-0198
3-1-1 Kameda-kogyodanchi, Konan-ku, Niigata-shi, Niigata
025-382-8879
y_higuchi@sk.kameda.co.jp
| 1st name | Takashi |
| Middle name | |
| Last name | Nakagawa |
EP Mediate Co., Ltd.
Foods Department, Trial Planning Section 2
162-0821
Kagurazaka AK Bldg., 1-8, Tsukudo-cho, Shinjuku-ku, Tokyo
080-7710-1146
nakagawa.takashi768@eps.co.jp
EP Mediate Co., Ltd
KAMEDA SEIKA Co., Ltd.
Profit organization
Medical Station Clinic Research Ethics Committee
3-12-8, Takaban, Meguroku, Tokyo
03-6452-2712
nakagawa.akiko297@eps.co.jp
NO
| 2024 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
| 2023 | Year | 06 | Month | 08 | Day |
| 2023 | Year | 06 | Month | 08 | Day |
| 2023 | Year | 06 | Month | 14 | Day |
| 2023 | Year | 12 | Month | 01 | Day |
| 2023 | Year | 06 | Month | 12 | Day |
| 2025 | Year | 08 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058547